Cellular models for Parkinson's disease

Journal of Neurochemistry

Volumn , Issue , 2016, Pages 121-130

  Falkenburger, Björn H ^a,b   Saridaki, Theodora ^a   Dinter, Elisabeth ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b JARA Translational Medicine   (Germany)

Author keywords

Dementia with Lewy bodies; FRET; non motor symptoms

Indexed keywords

ALPHA SYNUCLEIN; UBIQUITIN;

CELL DIFFERENTIATION; CELL PROLIFERATION; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; FLOW CYTOMETRY; FLUORESCENCE CORRELATION SPECTROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; LEWY BODY; NERVE CELL DEGENERATION; NONHUMAN; OLIGOMERIZATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; VENTRAL TEGMENTUM;

EID: 85027952525     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13618     Document Type: Review

References (77)

1. Aelvoet S. A., Ibrahimi A., Macchi F., Gijsbers R., Van den Haute C., Debyser Z. and Baekelandt V. (2014) Noninvasive bioluminescence imaging of -synuclein oligomerization in mouse brain using split firefly luciferase reporters. J. Neurosci. 34, 16518–16532.
2. Andersen J. K. (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10(Suppl), S18–S25.
3. Arrasate M., Mitra S., Schweitzer E. S., Segal M. R. and Finkbeiner S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805–810.
4. Ay M., Jin H., Harischandra D. S., Asaithambi A., Kanthasamy A., Anantharam V. and Kanthasamy A. G. (2015) Molecular cloning, epigenetic regulation, and functional characterization of Prkd1 gene promoter in dopaminergic cell culture models of Parkinson's disease. J. Neurochem. 135, 402–415.
5. Bae E.-J., Yang N.-Y., Song M., Lee C. S., Lee J. S., Jung B. C., Lee H.-J., Kim S., Masliah E., Sardi S. P. and Lee S-J. (2014) Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein. Nat. Commun. 5, 4755.
6. Bertoncini C. W., Jung Y.-S., Fernandez C. O., Hoyer W., Griesinger C., Jovin T. M. and Zweckstetter M. (2005) Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc. Natl Acad. Sci. USA 102, 1430–1435.
7. Bousset L., Pieri L., Ruiz-Arlandis G., Gath J., Jensen P. H., Habenstein B., Madiona K. et al. (2013) Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 4, 2575.
8. Braak H., Ghebremedhin E., Rüb U., Bratzke H. and Del Tredici K. (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318, 121–134.
9. Buerli T., Pellegrino C., Baer K., Lardi-Studler B., Chudotvorova I., Fritschy J.-M., Medina I. and Fuhrer C. (2007) Efficient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat. Protoc. 2, 3090–3101.
10. Butler E. K., Voigt A., Lutz A. K., Toegel J. P., Gerhardt E., Karsten P., Falkenburger B. H., Reinartz A., Winklhofer K. F. and Schulz J. B. (2012) The mitochondrial chaperone protein TRAP1 mitigates α-synuclein toxicity. PLoS Genet. 8, e1002488.
11. Chan C. S., Guzman J. N., Ilijic E., Mercer J. N., Rick C., Tkatch T., Meredith G. E. and Surmeier D. J. (2007) ‘Rejuvenation’ protects neurons in mouse models of Parkinson's disease. Nature 447, 1081–1086.
12. Chutna O., Gonçalves S., Villar-Piqué A., Guerreiro P., Marijanovic Z., Mendes T., Ramalho J. et al. (2014) The small GTPase Rab11 co-localizes with α-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity. Hum. Mol. Genet. 23, 6732–6745.
13. Cremades N., Cohen S. I. A., Deas E., Abramov A. Y., Chen A. Y., Orte A., Sandal M. et al. (2012) Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell 149, 1048–1059.
14. Danzer K. M., Kranich L. R., Ruf W. P., Cagsal-Getkin O., Winslow A. R., Zhu L., Vanderburg C. R. and McLean P. J. (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol. Neurodegener. 7, 42.
15. Dettmer U., Newman A. J., Luth E. S., Bartels T. and Selkoe D. (2013) In vivo cross-linking reveals principally oligomeric forms of α-synuclein and β-synuclein in neurons and non-neural cells. J. Biol. Chem. 288, 6371–6385.
16. Dragicevic E., Schiemann J. and Liss B. (2015) Dopamine midbrain neurons in health and Parkinson's disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels. Neuroscience 284, 798–814.
17. Ebrahimi-Fakhari D., Cantuti-Castelvetri I., Fan Z., Rockenstein E., Masliah E., Hyman B. T., McLean P. J. and Unni V. K. (2011) Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of -synuclein. J. Neurosci. 31, 14508–14520.
18. Ejlerskov P., Rasmussen I., Nielsen T. T., Bergström A.-L., Tohyama Y., Jensen P. H. and Vilhardt F. (2013) Tubulin polymerization-promoting protein (TPPP/p25α) promotes unconventional secretion of α-synuclein through exophagy by impairing autophagosome-lysosome fusion. J. Biol. Chem. 288, 17313–17335.
19. Espay A. J., LeWitt P. A. and Kaufmann H. (2014) Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement. Mov. Disord. 29, 1710–1719.
20. Falkenburger B. H. and Schulz J. B. (2006) Limitations of cellular models in Parkinson's disease research. J. Neural Transm. Suppl. 70, 261–268.
21. Fearnley J. M. and Lees A. J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114, 2283–2301.
22. Fountaine T. M., Venda L. L., Warrick N., Christian H. C., Brundin P., Channon K. M. and Wade-Martins R. (2008) The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons. Eur. J. Neurosci. 28, 2459–2473.
23. Freundt E. C., Maynard N., Clancy E. K., Roy S., Bousset L., Sourigues Y., Covert M., Melki R., Kirkegaard K. and Brahic M. (2012) Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport. Ann. Neurol. 72, 517–524.
24. Haas S. J.-P. and Wree A. (2002) Dopaminergic differentiation of the Nurr1-expressing immortalized mesencephalic cell line CSM14.1 in vitro. J. Anat. 201, 61–69.
25. Hasegawa T., Matsuzaki M., Takeda A., Kikuchi A., Akita H., Perry G., Smith M. A. and Itoyama Y. (2004) Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. Brain Res. 1013, 51–59.
26. Hermanson E., Joseph B., Castro D., Lindqvist E., Aarnisalo P., Wallén A., Benoit G., Hengerer B., Olson L. and Perlmann T. (2003) Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells. Exp. Cell Res. 288, 324–334.
27. Jang W., Kim H. J., Li H., Jo K. D., Lee M. K. and Yang H. O. (2015) The Neuroprotective Effect of Erythropoietin on Rotenone-Induced Neurotoxicity in SH-SY5Y Cells Through the Induction of Autophagy. Mol. Neurobiol. Jul 9. [Epub ahead of print]
28. Johansen T. and Lamark T. (2011) Selective autophagy mediated by autophagic adapter proteins. Autophagy 7, 279–296.
29. Juenemann K., Wiemhoefer A. and Reits E. A. (2015) Detection of ubiquitinated huntingtin species in intracellular aggregates. Front. Mol. Neurosci. 8, 1.
30. Kadigamuwa C. C., Le V. Q. and Wimalasena K. (2015) 2, 2”- and 4, 4-”Cyanines are transporter-independent in vitro dopaminergic toxins with the specificity and mechanism of toxicity similar to MPP(.). J. Neurochem. 135, 755–767.
31. Kahle P. J., Neumann M., Ozmen L., Muller V., Jacobsen H., Schindzielorz A., Okochi M. et al. (2000) Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J. Neurosci. 20, 6365–6373.
32. Karpinar D. P., Balija M. B. G., Kügler S., Opazo F., Rezaei-Ghaleh N., Wender N., Kim H.-Y. et al. (2009) Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. EMBO J. 28, 3256–3268.
33. Kepp O., Galluzzi L., Lipinski M., Yuan J. and Kroemer G. (2011) Cell death assays for drug discovery. Nat. Rev. Drug. Discov. 10, 221–237.
34. Kim I., Shu C.-W., Xu W., Shiau C.-W., Grant D., Vasile S., Cosford N. D. P. and Reed J. C. (2009) Chemical biology investigation of cell death pathways activated by endoplasmic reticulum stress reveals cytoprotective modulators of ASK1. J. Biol. Chem. 284, 1593–1603.
35. Kim C., Rockenstein E., Spencer B., Kim H.-K., Adame A., Trejo M., Stafa K., Lee H.-J., Lee S.-J. and Masliah E. (2015) Antagonizing neuronal toll-like receptor 2 prevents synucleinopathy by activating autophagy. Cell Rep. 13, 771–782.
36. Kimura S., Noda T. and Yoshimori T. (2007) Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3, 452–460.
37. Klucken J., Outeiro T. F., Nguyen P., McLean P. J. and Hyman B. T. (2006) Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. FASEB J. 20, 2050–2057.
38. Koch J. C., Bitow F., Haack J., d'Hedouville Z., Zhang J.-N., Tönges L., Michel U. et al. (2015) Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons. Cell Death Dis. 6, e1811.
39. Kopito R. R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524–530.
40. Krumova P., Meulmeester E., Garrido M., Tirard M., Hsiao H.-H., Bossis G., Urlaub H. et al. (2011) Sumoylation inhibits alpha-synuclein aggregation and toxicity. J. Cell Biol. 194, 49–60.
41. Kunadt M., Eckermann K., Stuendl A., Gong J., Russo B., Strauss K., Rai S. et al. (2015) Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation. Acta Neuropathol. 129, 695–713.
42. Larsen K. E., Fon E. A., Hastings T. G., Edwards R. H. and Sulzer D. (2002) Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J. Neurosci. 22, 8951–8960.
43. Larsen K. E., Schmitz Y., Troyer M. D., Mosharov E., Dietrich P., Quazi A. Z., Savalle M. et al. (2006) Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26, 11915–11922.
44. Li W., West N., Colla E., Pletnikova O., Troncoso J. C., Marsh L., Dawson T. M. et al. (2005) Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc. Natl Acad. Sci. USA 102, 2162–2167.
45. Liss B., Haeckel O., Wildmann J., Miki T., Seino S. and Roeper J. (2005) K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat. Neurosci. 8, 1742–1751.
46. Lotharius J., Barg S., Wiekop P., Lundberg C., Raymon H. K. and Brundin P. (2002) Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J. Biol. Chem. 277, 38884–38894.
47. Lotharius J., Falsig J., van Beek J., Payne S., Dringen R., Brundin P. and Leist M. (2005) Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J. Neurosci. 25, 6329–6342.
48. Macleod A. D., Taylor K. S. M. and Counsell C. E. (2014) Mortality in Parkinson's disease: a systematic review and meta-analysis. Mov. Disord. 29, 1615–1622.
49. Mahon M. J. (2011) pHluorin2: an enhanced, ratiometric, pH-sensitive green florescent protein. ABB 02, 132–137.
50. Martinez Martin P., Schapira A. H. V., Stocchi F., Sethi K., Odin P., MacPhee G., Brown R. G. et al. (2007) Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients. Mov. Disord. 22, 1623–1629.
51. McLean P. J., Kawamata H. and Hyman B. T. (2001) Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 104, 901–912.
52. Meka D. P., Müller-Rischart A. K., Nidadavolu P., Mohammadi B., Motori E., Ponna S. K., Aboutalebi H. et al. (2015) Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration. J. Clin. Invest. 125, 1873–1885.
53. Myeku N., Metcalfe M. J., Huang Q. and Figueiredo-Pereira M. (2011) Assessment of proteasome impairment and accumulation/aggregation of ubiquitinated proteins in neuronal cultures. Methods Mol. Biol. 793, 273–296.
54. Nath S., Meuvis J., Hendrix J., Carl S. A. and Engelborghs Y. (2010) Early aggregation steps in alpha-synuclein as measured by FCS and FRET: evidence for a contagious conformational change. Biophys. J. 98, 1302–1311.
55. Opazo F., Krenz A., Heermann S., Schulz J. B. and Falkenburger B. H. (2008) Accumulation and clearance of -synuclein aggregates demonstrated by time-lapse imaging. J. Neurochem. 106, 529–540.
56. Ossato G., Digman M. A., Aiken C., Lukacsovich T., Marsh J. L. and Gratton E. (2010) A two-step path to inclusion formation of huntingtin peptides revealed by number and brightness analysis. Biophys. J. 98, 3078–3085.
57. Pankiv S., Clausen T. H., Lamark T., Brech A., Bruun J.-A., Outzen H., Overvatn A., Bjørkøy G. and Johansen T. (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131–24145.
58. Parkkinen L., Kauppinen T., Pirttilä T., Autere J. M. and Alafuzoff I. (2005) Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann. Neurol. 57, 82–91.
59. Peelaerts W., Bousset L., Van der Perren A., Moskalyuk A., Pulizzi R., Giugliano M., Van den Haute C., Melki R. and Baekelandt V. (2015) α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340–344.
60. Peyrin J.-M., Deleglise B., Saias L., Vignes M., Gougis P., Magnifico S., Betuing S. et al. (2011) Axon diodes for the reconstruction of oriented neuronal networks in microfluidic chambers. Lab Chip 11, 3663.
61. Pieri L., Madiona K., Bousset L. and Melki R. (2012) Fibrillar α-synuclein and huntingtin exon 1 assemblies are toxic to the cells. Biophys. J. 102, 2894–2905.
62. Poehler A.-M., Xiang W., Spitzer P., May V. E. L., Meixner H., Rockenstein E., Chutna O. et al. (2014) Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment. Autophagy 10, 2171–2192.
63. Popova B., Kleinknecht A. and Braus G. H. (2015) Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast. Biomolecules 5, 617–634.
64. Roberti M. J., Bertoncini C. W., Klement R., Jares-Erijman E. A. and Jovin T. M. (2007) Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein. Nat. Methods 4, 345–351.
65. Roberti M. J., Jovin T. M. and Jares-Erijman E. (2011) Confocal fluorescence anisotropy and FRAP imaging of α-synuclein amyloid aggregates in living cells. PLoS ONE 6, e23338.
66. Schildknecht S., Karreman C., Pöltl D., Efrémova L., Kullmann C., Gutbier S., Krug A., Scholz D., Gerding H. R. and Leist M. (2013) Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases. ALTEX 30, 427–444.
67. Scholz D., Pöltl D., Genewsky A., Weng M., Waldmann T., Schildknecht S. and Leist M. (2011) Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J. Neurochem. 119, 957–971.
68. Schulz-Schaeffer W. J. (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson”s disease and Parkinson”s disease dementia. Acta Neuropathol. 120, 131–143.
69. Schulz-Schaeffer W. J. (2012) Neurodegeneration in Parkinson disease: moving Lewy bodies out of focus. Neurology 79, 2298–2299.
70. Smith W. W., Margolis R. L., Li X., Troncoso J. C., Lee M. K., Dawson V. L., Dawson T. M., Iwatsubo T. and Ross C. A. (2005) Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. J. Neurosci. 25, 5544–5552.
71. Spinelli K. J., Taylor J. K., Osterberg V. R., Churchill M. J., Pollock E., Moore C., Meshul C. K. and Unni V. K. (2014) Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease. J. Neurosci. 34, 2037–2050.
72. Sulzer D. and Surmeier D. J. (2013) Neuronal vulnerability, pathogenesis, and Parkinson's disease. Mov. Disord. 28, 715–724.
73. Tanaka M., Kim Y. M., Lee G., Junn E., Iwatsubo T. and Mouradian M. M. (2004) Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J. Biol. Chem. 279, 4625–4631.
74. Trimmer P. A., Borland M. K., Keeney P. M., Bennett J. P. and Jr Parker. W. D.Jr. (2004) Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies. J. Neurochem. 88, 800–812.
75. Volpicelli-Daley L. A., Luk K. C., Patel T. P., Tanik S. A., Riddle D. M., Stieber A., Meaney D. F., Trojanowski J. Q. and Lee V. M. Y. (2011) Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57–71.
76. Volpicelli-Daley L. A., Gamble K. L., Schultheiss C. E., Riddle D. M., West A. B. and Lee V. M. Y. (2014) Formation of α-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes. Mol. Biol. Cell 25, 4010–4023.
77. Zaarur N., Meriin A. B., Bejarano E., Xu X., Gabai V. L., Cuervo A. M. and Sherman M. Y. (2014) Proteasome failure promotes positioning of lysosomes around the aggresome via local block of microtubule-dependent transport. Mol. Cell. Biol. 34, 1336–1348.